Sen. John Hoeven bought AbbVie (ABBV)
Sen. John Hoeven (R-ND) · $50K–$100K · traded Mar 31, 2014
- Transaction
- Bought
- Amount
- $50K–$100K
- Owner
- The member
- Traded
- Mar 31, 2014
- Disclosed
- Apr 23, 2014
- Days to disclose
- 23
- Asset type
- Stock
- As filed
- AbbVie Inc. (NYSE)
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- Apr 23, 2014$50K–$100K
Bought Anheuser-Busch InBev SA/NV BUD
$50K–$100K · Traded Mar 31, 2014 · disclosed Apr 23, 2014
Recent Congress trades in ABBV
- Oct 9, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 9, 2026 · Spouse
- Sep 21, 2026$15K–$50K
Rep. Pete Sessions (R-TX-17)
$15K–$50K · Traded Sep 14, 2026 · disclosed Sep 21, 2026
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 11, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded May 1, 2026 · disclosed Jun 11, 2026 · Dependent
- Jun 4, 2026$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
$1K–$15K · Traded May 5, 2026 · disclosed Jun 4, 2026 · Joint
- Feb 10, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Jan 29, 2026 · disclosed Feb 10, 2026 · Spouse
- Jan 16, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
$1K–$15K · Traded Dec 18, 2025 · disclosed Jan 16, 2026 · Joint
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
$1K–$15K · Traded Dec 8, 2025 · disclosed Jan 13, 2026
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.